{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:10:18Z","timestamp":1793927418624,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101034427"],"award-info":[{"award-number":["101034427"]}],"id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.gim.2025.101655","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T07:52:22Z","timestamp":1764661942000},"page":"101655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Economic evaluation of next-generation sequencing technologies in pediatric patient groups with confirmed or possible rare diseases: A systematic literature review"],"prefix":"10.1016","volume":"28","author":[{"given":"Marianna","family":"De Stefano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8130-9858","authenticated-orcid":false,"given":"Rudolf","family":"van Olden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3954-4772","authenticated-orcid":false,"given":"Elnaz","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3511-2822","authenticated-orcid":false,"given":"Lasse","family":"de Fries Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1618-7386","authenticated-orcid":false,"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-9870","authenticated-orcid":false,"given":"Alessandra","family":"Ferlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6719-0038","authenticated-orcid":false,"given":"Carl Rudolf","family":"Blankart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4824-0260","authenticated-orcid":false,"given":"Rachel","family":"Cassidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.gim.2025.101655_bib1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","article-title":"Genomic newborn screening for rare diseases","volume":"24","author":"Stark","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"2","key":"10.1016\/j.gim.2025.101655_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41431-019-0508-0","article-title":"Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database","volume":"28","author":"Nguengang Wakap","year":"2020","journal-title":"Eur J Hum Genet"},{"issue":"7","key":"10.1016\/j.gim.2025.101655_bib4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3390\/biology12070997","article-title":"Next-generation sequencing technology: current trends and advancements","volume":"12","author":"Satam","year":"2023","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13023-023-02916-x","article-title":"Rare diseases\u2019 genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project","volume":"18","author":"Ferlini","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gim.2025.101655_bib6","series-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2015"},{"issue":"10","key":"10.1016\/j.gim.2025.101655_bib7","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/gim.2017.247","article-title":"Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature","volume":"20","author":"Schwarze","year":"2018","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.gim.2025.101655_bib8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41431-018-0175-6","article-title":"Economic evaluation of genomic sequencing in the paediatric population: a critical review","volume":"26","author":"Alam","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"9","key":"10.1016\/j.gim.2025.101655_bib9","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jval.2018.06.017","article-title":"Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions","volume":"21","author":"Phillips","year":"2018","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41436-018-0024-6","article-title":"Clinical application of genome and exome sequencing as a diagnostic tool for pediatric patients: a scoping review of the literature","volume":"21","author":"Smith","year":"2019","journal-title":"Genet Med"},{"issue":"sup1","key":"10.1016\/j.gim.2025.101655_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/13696998.2021.2009725","article-title":"Economic evaluations of exome and genome sequencing in pediatric genetics: considerations towards a consensus strategy","volume":"24","author":"Olde Keizer","year":"2021","journal-title":"J Med Econ"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.healthpol.2022.03.001","article-title":"Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: systematic review and meta-analysis of cost-effectiveness evidence","volume":"126","author":"Nurchis","year":"2022","journal-title":"Health Policy"},{"issue":"10","key":"10.1016\/j.gim.2025.101655_bib13","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.gim.2022.06.004","article-title":"Cost-effectiveness frameworks for comparing genome and exome sequencing versus conventional diagnostic pathways: a scoping review and recommended methods","volume":"24","author":"Ferket","year":"2022","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.gim.2025.101655_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/cge.14313","article-title":"Economic evaluation of next-generation sequencing techniques in diagnosis of genetic disorders: a systematic review","volume":"103","author":"Rezapour","year":"2023","journal-title":"Clin Genet"},{"key":"10.1016\/j.gim.2025.101655_bib15","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated health economic evaluation reporting standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR Cheers II good practices task force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12962-024-00537-0","article-title":"Economic evaluations of medical devices in paediatrics: a systematic review and a quality appraisal of the literature","volume":"22","author":"Mascarenhas","year":"2024","journal-title":"Cost Eff Resour Alloc"},{"issue":"7","key":"10.1016\/j.gim.2025.101655_bib19","doi-asserted-by":"crossref","first-page":"E2371","DOI":"10.1002\/lary.29356","article-title":"Exome sequencing for isolated congenital hearing loss: a cost-effectiveness analysis","volume":"131","author":"Downie","year":"2021","journal-title":"Laryngoscope"},{"issue":"6","key":"10.1016\/j.gim.2025.101655_bib20","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/epi.14087","article-title":"A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy","volume":"59","author":"Howell","year":"2018","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.gim.2025.101655_bib21","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1016\/j.ekir.2021.08.028","article-title":"Cost-effectiveness of targeted exome analysis as a diagnostic test in glomerular diseases","volume":"6","author":"Jayasinghe","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2337\/dc18-0261","article-title":"Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life","volume":"42","author":"Johnson","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.gim.2025.101655_bib23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/mgg3.355","article-title":"Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: evidence of clinical utility and cost effectiveness","volume":"6","author":"Palmer","year":"2018","journal-title":"Mol Genet Genomic Med"},{"key":"10.1016\/j.gim.2025.101655_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41525-017-0006-7","article-title":"Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases","volume":"2","author":"Schofield","year":"2017","journal-title":"NPJ Genom Med"},{"issue":"11","key":"10.1016\/j.gim.2025.101655_bib25","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1038\/s41436-019-0534-x","article-title":"Long-term economic impacts of exome sequencing for suspected monogenic disorders: diagnosis, management, and reproductive outcomes","volume":"21","author":"Schofield","year":"2019","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.gim.2025.101655_bib26","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/gim.2018.37","article-title":"Meeting the challenges of implementing rapid genomic testing in acute pediatric care","volume":"20","author":"Stark","year":"2018","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41436-018-0006-8","article-title":"Does genomic sequencing early in the diagnostic trajectory make a difference? A follow-up study of clinical outcomes and cost-effectiveness","volume":"21","author":"Stark","year":"2019","journal-title":"Genet Med"},{"issue":"8","key":"10.1016\/j.gim.2025.101655_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/gim.2016.221","article-title":"Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement","volume":"19","author":"Stark","year":"2017","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.gim.2025.101655_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamapediatrics.2017.1755","article-title":"Diagnostic impact and cost-effectiveness of whole-exome sequencing for ambulant children with suspected monogenic conditions","volume":"171","author":"Tan","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.gim.2025.101655_bib30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41431-021-00916-8","article-title":"Genomic sequencing for the diagnosis of childhood mitochondrial disorders: a health economic evaluation","volume":"30","author":"Wu","year":"2022","journal-title":"Eur J Hum Genet"},{"issue":"11","key":"10.1016\/j.gim.2025.101655_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100942","article-title":"Genomic testing for suspected monogenic kidney disease in children and adults: a health economic evaluation","volume":"25","author":"Wu","year":"2023","journal-title":"Genet Med"},{"issue":"12","key":"10.1016\/j.gim.2025.101655_bib32","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/s41436-020-0929-8","article-title":"A cost-effectiveness analysis of genomic sequencing in a prospective versus historical cohort of complex pediatric patients","volume":"22","author":"Yeung","year":"2020","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41397-022-00277-5","article-title":"Real-world economic evaluation of prospective rapid whole-genome sequencing compared to a matched retrospective cohort of critically ill pediatric patients in the United States","volume":"22","author":"Diaby","year":"2022","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gim.2021.08.015","article-title":"Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases","volume":"24","author":"Incerti","year":"2022","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.gim.2025.101655_bib35","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.gim.2022.03.005","article-title":"Cost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions","volume":"24","author":"Lavelle","year":"2022","journal-title":"Genet Med"},{"issue":"10","key":"10.1016\/j.gim.2025.101655_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1038\/s41436-021-01210-0","article-title":"Diagnosing newborns with suspected mitochondrial disorders: an economic evaluation comparing early exome sequencing to current typical care","volume":"23","author":"Crawford","year":"2021","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100797","article-title":"Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: estimates from the PreEMPT model","volume":"25","author":"Christensen","year":"2023","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2024.101069","article-title":"Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: evidence from Canada","volume":"26","author":"Regier","year":"2024","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40258-018-0390-x","article-title":"Cost-effectiveness of genome and exome sequencing in children diagnosed with autism spectrum disorder","volume":"16","author":"Yuen","year":"2018","journal-title":"Appl Health Econ Health Policy"},{"issue":"11","key":"10.1016\/j.gim.2025.101655_bib40","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/gim.2017.47","article-title":"A microcosting and cost\u2013consequence analysis of clinical genomic testing strategies in autism spectrum disorder","volume":"19","author":"Tsiplova","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101655_bib41","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejpn.2021.11.006","article-title":"Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children","volume":"36","author":"Aaltio","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/genes13010036","article-title":"Diagnostic yield and economic implications of whole-exome sequencing for ASD diagnosis in Israel","volume":"13","author":"Tal-Ben Ishay","year":"2021","journal-title":"Genes (Basel)"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.53514","article-title":"Cost-effectiveness of Whole-Genome vs Whole-Exome sequencing among children with suspected genetic disorders","volume":"7","author":"Nurchis","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12962-024-00552-1","article-title":"An overview of the perspectives used in health economic evaluations","volume":"22","author":"Sittimart","year":"2024","journal-title":"Cost Eff Resour Alloc"},{"issue":"12","key":"10.1016\/j.gim.2025.101655_bib45","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.gim.2022.08.030","article-title":"Correspondence on \u201cCost-effectiveness of exome and genome sequencing for children with rare and undiagnosed conditions\u201d by Lavelle et al","volume":"24","author":"Grosse","year":"2022","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S0266462314000464","article-title":"Generating health technology assessment evidence for rare diseases","volume":"30","author":"Facey","year":"2014","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"10.1016\/j.gim.2025.101655_bib47","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajhg.2023.01.018","article-title":"Australian Genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare","volume":"110","author":"Stark","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gim.2025.101655_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2024.105162","article-title":"The modernisation of newborn screening as a pan-European challenge\u2014an international Delphi study","volume":"149","author":"Gillner","year":"2024","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.gim.2025.101655_bib49","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40120-023-00489-2","article-title":"Cost effectiveness of newborn screening for spinal muscular atrophy in England","volume":"12","author":"Weidlich","year":"2023","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ajhg.2018.11.016","article-title":"Interpretation of genomic sequencing results in healthy and ill newborns: results from the BabySeq project","volume":"104","author":"Ceyhan-Birsoy","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jimd.12704","article-title":"Whole genome sequencing to screen 100 000 newborns for treatable genetic disorders","volume":"47","author":"Rahman","year":"2024","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.gim.2025.101655_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13023-025-03692-6","article-title":"TREAT: systematic and inclusive selection process of genes for genomic newborn screening as part of the Screen4Care project","volume":"20","author":"Saier","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.gim.2025.101655_bib53","author":"Berthereau"},{"issue":"5","key":"10.1016\/j.gim.2025.101655_bib54","first-page":"22","article-title":"Valuing the health of children","volume":"8","year":"2022","journal-title":"Value Outcomes Spotlight"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025003028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025003028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T19:03:21Z","timestamp":1773947001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1098360025003028"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101655","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Economic evaluation of next-generation sequencing technologies in pediatric patient groups with confirmed or possible rare diseases: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101655","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101655"}}